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Type II fatty acid synthesis (FAS) pathway of Plasmodium falciparum is a validated unique target for developing novel antimalarials due to its intrinsic differences from Type I pathway operating in humans. β-Ketoacyl-acyl carrier protein reductase (FabG) is the only enzyme of this pathway, which has no isoforms, thus selective inhibitors can be developed for this player of the pathway. This thesis describes the successful cloning of FabG from Plasmodium falciparum, its expression in E. coli, single step affinity purification, kinetic characterization and its interaction with PfACP. The enzyme has a Km (app) value for the substrate acetoacetyl-CoA of 0.43 + 0.05 mM and Km (app) value for NADPH of 42.6 + 0.05 μM. The specific activity of the enzyme with acetoacetyl-CoA is 59.8 U mg-1 and the kcat is 259 + 25 s-1. The study was executed to gain insights into the structure and function of PfFabG to get better understanding of the interactions with its substrate and product analogs and acyl carrier protein (PfACP). Binding of the reduced co-factor, makes the enzyme catalytically efficient, as it increases the binding affinity of the substrate acetoacetyl-CoA, 16 fold. The binding affinity of PfACP to the enzyme also increases by 3 fold upon NADPH binding. Plasmodium FabG exhibits negative, homotropic co-operative binding for NADPH, which is enhanced in presence of acyl carrier protein. There are two NADPH and one PfACP binding sites in PfFabG in the absence of each other, whereas the fully active enzyme has two equivalent and inter-dependent NADPH and two PfACP binding sites. NADPH induced conformational changes were studied using the chaotropic denaturants. Differential denaturation of PfFabG was observed with urea and GdmCl in presence of NADPH, the active site organizer. Also, the residues of PfFabG important for the interaction with PfACP were successfully elucidated. It was found that the highly conserved α-II helix of ACP recognizes a positively charged hydrophobic patch on the FabG. Kinetic analysis and direct binding studies between PfFabG and PfACP confirmed the identification of Arg187 and Arg230 as critical for PfFabG-PfACP interaction.

Type II fatty acid synthesis (FAS) pathway of Plasmodium falciparum is a validated unique target for developing novel antimalarials due to its intrinsic differences from type I pathway operating in humans. beta-Ketoacyl-acyl carrier protein reductase (FabG) performs the NADPH-dependent reduction of beta-ketoacyl-ACP to beta-hydroxyacyl-ACP, the first reductive step in the elongation cycle of fatty acid biosynthesis. In this paper we report intensive studies on the direct interactions of Plasmodium FabG and Plasmodium acyl carrier protein (ACP) in solution, in presence and absence of its co-factor, NADPH, by monitoring the change in intrinsic fluorescence of PfFabG and by surface plasmon resonance. To address the issue of importance of the residues involved in a strong, specific and stoichiometric binding of PfFabG to PfACP, we mutated Arg-187, 190 and 230 of PfFabG. The activities of the mutants were assessed using both an ACP-dependent and an ACP-independent assay. The affinity of all the PfFabG mutants were reduced for acetoacetyl-ACP (the physiological substrate) as compared to wild type PfFabG to different extents, but were equally active in biochemical assays with the substrate analog acetoacetyl-CoA. Kinetic analysis and direct binding studies between PfFabG and PfACP confirmed the identification of Arg-187 and Arg-230 as critical residues for the PfFabG-PfACP interactions. Our studies thus reveal the significance of the positively charged/ hydrophobic patch located adjacent to the active site cavities of the Plasmodium beta-ketoacyl-ACP reductase, for interactions with PfACP.

The urea and guanidine chloride induced unfolding of FabG, a β-ketoacyl-ACP reductase was examined in detail using intrinsic fluorescence of FabG, UV- circular dichroism (CD), spectrophotometric enzyme activity measurements, glutaraldehyde cross-linking  and size exclusion chromatography. The equilibrium unfolding of FabG by urea is a multistep process as compared to two state processes by guanidine chloride. FabG is fully unfolded at 6.0 M urea and 4.0 M guanidine chloride (GdmCl). Approximately 90% of the enzyme activity could be recovered on dialyzing the denaturants. We found two states in the reversible unfolding process of FabG in the presence of NADPH; one is an activity-enhanced state and the other, an inactive state in case or equilibrium unfolding with urea. On the contrary, in presence of NADPH, there is no stabilization of FabG in case of equilibrium unfolding with GdmCl. We hypothesize that the hydrogen-bonding network may be reorganized by the denaturant in the activity-enhanced state formed in the presence of 1.0 M urea, by interrupting the association between dimer-dimer interface and help in accommodating the larger substrate in the substrate binding tunnel, thus increase the activity. Furthermore, binding of the active site organizer, NADPH leads to compaction of the FabG in presence of urea, as evident by acrylamide quenching. We have shown here for the first time, the detailed inactivation kinetics of FabG, which have not been evaluated in the past from any of the FabG family of enzymes from any source. These findings provide impetus for exploring the influences of ligands on the structure-activity relationship of Plasmodium β-ketoacyl-ACP reductase.

The conformational stability of the homotetrameric Plasmodium falciparum β-ketoacyl-ACP reductase (FabG) was determined by both isothermal guanidinium chloride induced and thermal denaturation in the presence of GdmCl. The reversible unfolding transitions were monitored by intrinsic fluorescence, circular dichroism (CD) spectroscopy and by measuring the enzyme activity of FabG. The denaturation profiles were analyzed to obtain the thermodynamic parameters associated with unfolding of the protein. The data not only confirm to the simple   model of unfolding, based on the superimposability of CD and fluorescence transition and similar ∆G estimates for denaturation curves obtained at four different concentration of the FabG, but also well described by the linear extrapolation model for the nature of denaturant-protein interaction. In addition, both the conformational stability (∆Gs) and the ∆Cp for the protein unfolding is quite high, at about 22.68 kcal/mole and 5.83 kcal/ (mole K), respectively, which may be a reflection of the relatively larger size of the tetrameric molecule ( Mr 120, 000) and a consequent larger buried hydrophobic core in the folded protein. We have shown here for the first time, the detailed biophysical characterization of FabG, which have not been evaluated in the past from any of the FabG family of enzymes from any source. Our study can serve as prototype for conformational stability of other members of short-chain alcohol dehydrogenase/reductase super family.      

Type II fatty acid synthesis (FAS) pathway of Plasmodium falciparum is a validated unique target for developing novel antimalarials due to its intrinsic differences from Type I pathway operating in humans. beta-Ketoacyl-acyl carrier protein reductase (FabG) is the only enzyme of this pathway, which has no isoforms, thus selective inhibitors can be developed for this player of the pathway. We report here intensive studies on the direct interactions of Plasmodium FabG with its co-factor NADPH, acyl carrier protein (ACP), acetoacetyl-CoA and other ligands in solution by monitoring the intrinsic fluorescence (λmax 334 nm) of the protein due to its lone tryptophan, as well as the fluorescence of NADPH (λmax 450 nm) upon its binding to the enzyme. Binding of the reduced co-factor, makes the enzyme catalytically efficient, as it increases the binding affinity of the substrate acetoacetyl-CoA, 16 fold. The binding affinity of ACP to the enzyme also increases ~3 fold upon NADPH binding. Plasmodium FabG exhibits negative, homotropic co-operative binding for NADPH, which is enhanced in presence of acyl carrier protein. ACP increases the accessibility of NADPH to FabG, as evident from the increase in the accessibility of the tryptophan of FabG to acrylamide from 81% to 98%. In presence of NADP+, the reaction proceeds in reverse direction (Ka=23.17 μM-1). These findings provide impetus for exploring the influence of ligands on the structure-activity relationship of Plasmodium β-ketoacyl-ACP reductase.

A recombinant form of Plasmodium falciparum β-ketoacyl ACP reductase (PfFabG) was overexpressed in Escherichia coli BL-21 codon plus (DE3). The resulting insoluble inclusion bodies were separated from cellular debris by extensive washing with buffer containing 0.05% Tween-20 and solubilized by homogenization with 8 M urea. Attempts to refold PfFabG from solubilized inclusion bodies employing Rotofor (separation based on different pIs of proteins in a mixture) followed by Ni2+ or cation exchange chromatography were not successful either by bringing down the urea concentration instantaneously, stepwise, or by dialysis. Denatured PfFabG was therefore initially purified by cation exchange chromatography and was then correctly refolded at a final concentration of 100-200 μg/ml in a 20 mM Na-acetate buffer pH 5.3 with 300 mM NaCl, 10% glycerol and 0.05% Tween-20. The protein was found to be properly folded only in the presence of the cofactor NADPH and salt at a concentration < 300 mM by drop dilution method at 2-80C for 12 h. The purified final product was >98% pure by denaturing gel electrophoresis. The purified protein was biologically active in a standard enzymatic assay using acetoacetyl-CoA as a substrate. The enzyme was found to be stable up to fourth day of purification and glycerol was found to stabilize enzyme activity for several weeks, during storage. This effort paves the way for elucidation of the structure-function correlations for PfFabG as well as exploration of the enzyme for developing inhibitors against it for combating malaria.

